View Single Post
Old 28-08-2017, 04:04 PM   #12
st jimmy
Senior Member
 
Join Date: May 2016
Location: Amsterdam, Netherlands
Posts: 2,299
Likes: 1,499 (899 Posts)
Default

According to the following scientific looking report, gemcitabine-based chemotherapy is highly superior to a combination of pancreatic enzymes, nutritional supplements, detoxification, and an organic diet for the treatment of pancreatic cancer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2860407/

Quote:
At enrollment, the treatment groups had no statistically significant differences in patient characteristics, pathology, quality of life, or clinically meaningful laboratory values. Kaplan-Meier analysis found a 9.7-month difference in median survival between the chemotherapy group (median survival, 14 months) and enzyme treatment groups (median survival, 4.3 months) and found an adjusted-mortality hazard ratio of the enzyme group compared with the chemotherapy group of 6.96 (P < .001). At 1 year, 56% of chemotherapy-group patients were alive, and 16% of enzyme-therapy patients were alive. The quality of life ratings were better in the chemotherapy group than in the enzyme-treated group (P < .01).
st jimmy is offline   Reply With Quote